Prevalence and Genotypic Characterization of Extended- Spectrum Beta-Lactamases Produced by Gram Negative Bacilli at a Tertiary Care Hospital in Rural South Western Uganda
Acaku Moses, Freddie Bwanga, Yap Boum, Joel Bazira
Microbiology Research Journal International · pp. 1541–1550 · Published 22 Aug 2014
10.9734/BMRJ/2014/9792Abstract
Aim: To determine the prevalence and genotypic characterisation of extended spectrum beta-lactamases produced by gram negative bacilli isolated at Mbarara Regional Referral Hospital (MRRH). Samples: Gram negative clinical isolates. Study Design: Laboratory-based descriptive cross-sectional study. Place and Duration of the Study: MRRH, June and August 2012. Methods: Gram negative clinical isolates were sub cultured, and identified using biochemical tests. They were screened for ESBL by using oxyimino-cephalosporins and confirmed by double disc synergy Genotyping was performed using the PCR for TEM, SHV and CTX-M. Susceptibility pattern for the extended spectrum beta-lactamases, (ESBL) - positive isolates to other antibiotic classes was performed by the Kirby Bauer Technique. Results: A total of 484 isolates were included in the study. The commonest ESBL producers were Escherichia coli (34%), followed by unidentified coliforms (19.3%) and Klebsiella spp. (12.7%). Phenotypically, 88/484 were ESBL producers while genotypically 213/ 484 possessed ESBL genes. The ESBL genes were blaCTX-M (146; 70%), blaSHV (72; 34%) and blaTEM (100; 47%). 87of 213 isolates expressed more than one ESBL gene. Of these 36 (7.4%) produced blaCTX-M/blaSHV, 28 (5.8%) blaCTX-M /blaTEM, 4 (0.8%) blaSHV/ blaTEM and 19 (3.9%) blaCTX-M/blaSHV/blaTEM. Sixty two (16%) were phenotypically and genotypically positive, 12 (3%) of the isolates were phenotypically positive but genotypically negative and 140 (37%) isolates were phenotypically negative but genotypically positive. The ESBL producers were highly susceptible to imipenem (95%), nitrofurantoin (66%) but less susceptible to ampicillin (4%) and ticarcillin (7%). Conclusion: ESBL production among the Gram-negative clinical isolates at MRRH is very high with several isolates possessing multiple genes. The ESBL producers are highly susceptible to imipenem, but very resistant to ciprofloxacin.
References (25)
- 1 Clinical and Laboratory Standards Institute [DOI]
- 2 Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America [DOI]
- 3 Updated Functional Classification of β-Lactamases [DOI]
- 4 Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community [DOI]
- 5 Mortality and delay in effective therapy associated with extended-spectrum -lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis [DOI]
- 6 Bailey & Scott's diagnostic microbiology
- 7 Analysis of Antibiotic Resistance Genes in Multidrug-Resistant Acinetobacter sp. Isolates from Military and Civilian Patients Treated at the Walter Reed Army Medical Center [DOI]
- 8 Predictors of Mortality in Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae : Importance of Inadequate Initial Antimicrobial Treatment [DOI]
- 9 Extended-Spectrum β-Lactamases in Klebsiella pneumoniae Bloodstream Isolates from Seven Countries: Dominance and Widespread Prevalence of SHV- and CTX-M-Type β-Lactamases [DOI]
- 10 Determining incidence of extended spectrum β-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001–2002 [DOI]
- 11 Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum β-lactamases [DOI]
- 12 Epidemiological Investigation of Fluoroquinolone Resistance in Infections Due to Extended‐Spectrum β‐Lactamase–ProducingEscherichia coliandKlebsiella pneumoniae [DOI]
- 13 Occurrence of Extended-Spectrum β-Lactamases in Members of the Family Enterobacteriaceae in Italy: Implications for Resistance to β-Lactams and Other Antimicrobial Drugs [DOI]
- 14 Antibiotic Coresistance in Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae and In Vitro Activity of Tigecycline [DOI]
- 15 High Levels of Antimicrobial Coresistance among Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae [DOI]
- 16 Extended spectrum beta-lactamase detection in gram-negative bacilli of nosocomial origin [DOI]
- 17 PER, CTX-M, TEM and SHV Beta-lactamases in Clinical Isolates of Klebsiella pneumoniae Isolated from Tehran, Iran [DOI]
- 18 Colonization dynamics of ampicillin-resistant Escherichia coli in the infantile colonic microbiota [DOI]
- 19 Genotypic versus Phenotypic methods to detect Extended-Spectrum Beta-Lactamases (ESBLs) in Uropathogenic Escherichia coli
- 20 Clinical Significance and Impact on Mortality of Extended-spectrum Beta Lactamase-producing Enterobacteriaceae Isolates in Nosocomial Bacteremia [DOI]
- 21 ESBL- FROM PETRI DISH TO THE PATIENT [DOI]
- 22 Frequency of extended spectrum beta lactamase producing gram negative bacilli among clinical isolates at clinical laboratories of Army Medical College, Rawalpindi.
- 23 AmpC beta lactamases among ESBL producing Escherichia coli and Klebsiella pneumoniae - If you don't look, you won't find
- 24 Extended spectrum beta-lactamases inEschericia coliisolated from community-acquired urinary tract infections in the Gaza Strip, Palestine [DOI]
- 25 Phenotypic and genotypic assay for detection of extended spectrum β-lactamases production by Klebsiella pneumoniae isolates in Emam Reza Hospital in Tabriz, Iran
Cited by 38
Henry Zamarano, J. Iramiot, E. Mulogo · Cureus · 2026
Muzafaru Twinomujuni, B. Musinguzi, M. Asiimwe · Access Microbiology · 2026
Alice Namatovu, B. Vahwere, Ibrahim Ntulume · BMC Infectious Diseases · 2025
M. Lubwama, D. Kateete, George Katende · Infection and Drug Resistance · 2024
M. Chaudhary, I. Jadhav, M. Banjara · Journal of Advances in Medicine and Medical Research · 2021
O. G. Onduru, R. Mkakosya, S. Rumisha · Tropical Medicine and Infectious Disease · 2021
O. G. Onduru, R. Mkakosya, S. Aboud · The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2021
Onduru Gervas Onduru, R. Mkakosya, S. Aboud · 2021
Herbert Mbyemeire, Kenneth Ssekatawa, C. Kato · Alexandria Journal of Medicine · 2021
Ali H. Hammadi · Indian Journal of Forensic Medicine & Toxicology · 2020
Showing 33 of 38 known citations — external sources report more than can currently be individually listed.
Related research
- Profile of Drug Resistant Gram Negative Bacteria from ICU at a Tertiary Care Center of India — shares topic coverage
- Characterization of the Genetic Supports for Betalactam Resistance in Escherichia coli Strains of Porcine Origin Producing Extended-spectrum Beta-Lactamase (ESBL) — shares topic coverage
- Evaluation of the NDP Test, a Novel Chromogenic Test for Rapid Detection of Extended Spectrum β-Lactamase Producing Enterobacteriaceae — shares topic coverage
- Detection of Hypervirulent Klebsiella pneumoniae in Tanta University Hospital, Egypt — shares topic coverage
- Antibiotic Susceptibility Test of Klebsiella pneumoniae and K. oxytoca Isolated from Different Clinical Samples and Perform Random Amplified Polymorphic DNA among K. pneumoniae — shares topic coverage
Article metrics
Real usage data collected on this platform.
166
Page views
0
PDF downloads
50
Outbound clicks
38
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.